TrialBrain communications2025
Phase 1, randomized trials of MEDI1341: cerebrospinal fluid free α-synuclein lowered by >50.
Craig Shering et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
TrialBrain communications2025
Craig Shering et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.